By John Kruzel
WASHINGTON - The U.S. Supreme Court on Monday declined to hear a bid by Sanofi SA to revive its antitrust lawsuit accusing rival pharmaceutical company Viatris Inc of illegally monopolizing the market with its EpiPen auto-injector, a device used to treat severe allergic reactions.
The justices turned away Sanofi's appeal of a lower court's ruling rejecting the French company's claim that Canonsburg, Pennsylvania-based Viatris had effectively cornered the market through exclusive deals with prescription drug intermediaries.
(Reporting by John Kruzel; Editing by Will Dunham)